These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6695731)

  • 1. Flecainide toxicity.
    Spivack C; Gottlieb S; Miura DS; Somberg JC
    Am J Cardiol; 1984 Jan; 53(2):329-30. PubMed ID: 6695731
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flecainide-induced aggravation of ventricular arrhythmias.
    Wehr M; Noll B; Krappe J
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1643-4. PubMed ID: 4003313
    [No Abstract]   [Full Text] [Related]  

  • 4. Exercise-induced ventricular tachycardia as a manifestation of flecainide toxicity.
    Hoffmann A; Wenk M; Follath F
    Int J Cardiol; 1986 Jun; 11(3):353-5. PubMed ID: 3721634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinusoidal ventricular tachycardia associated with flecainide acetate.
    Sellers TD; DiMarco JP
    Chest; 1984 May; 85(5):647-9. PubMed ID: 6201323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide.
    Goy JJ; Grbic M; Hurni M; Finci L; Maendly R; Duc J; Sigwart U
    Eur Heart J; 1985 Jun; 6(6):518-24. PubMed ID: 4043101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory ventricular tachycardia with flecainide.
    Wynn J; Fingerhood M; Keefe D; Maza S; Miura D; Somberg JC
    Am Heart J; 1986 Jul; 112(1):174-5. PubMed ID: 3728275
    [No Abstract]   [Full Text] [Related]  

  • 8. Flecainide: a new antiarrhythmic drug.
    Med Lett Drugs Ther; 1986 Feb; 28(707):19-20. PubMed ID: 3951388
    [No Abstract]   [Full Text] [Related]  

  • 9. Ventricular tachycardia associated with flecainide.
    Muhiddin K; Nathan AW; Hellestrand KJ; Banim SO; Camm AJ
    Lancet; 1982 Nov; 2(8309):1220-1. PubMed ID: 6128526
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacodynamics and side effects of flecainide acetate.
    Salerno DM; Granrud G; Sharkey P; Krejci J; Larson T; Erlien D; Berry D; Hodges M
    Clin Pharmacol Ther; 1986 Jul; 40(1):101-7. PubMed ID: 3720173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; ten Cate FJ; Jovanovic A; Hagemeijer F; Withagen A; Polak BC; Roelandt J; Hugenholtz PG
    Eur Heart J; 1984 Oct; 5(10):814-23. PubMed ID: 6499854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide-induced QT prolongation and ventricular tachycardia.
    Lui HK; Lee G; Dietrich P; Low RI; Mason DT
    Am Heart J; 1982 Apr; 103(4 Pt 1):567-9. PubMed ID: 7064795
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of intravenous flecainide in the treatment of acute ventricular arrhythmia].
    Aliot E; Baille N; Zannad F; Gilgenkrantz JM
    Ann Cardiol Angeiol (Paris); 1983 Oct; 32(6):417-23. PubMed ID: 6666988
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiarrhythmic therapy with flecainide in combination and comparison with propranolol.
    Stern H; Scheininger M; Theisen F; Theisen K
    Drugs; 1985; 29 Suppl 4():77-85. PubMed ID: 4006784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.
    Duff HJ; Roden DM; Maffucci RJ; Vesper BS; Conard GJ; Higgins SB; Oates JA; Smith RF; Woosley RL
    Am J Cardiol; 1981 Dec; 48(6):1133-40. PubMed ID: 7304461
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral flecainide acetate for the treatment of ventricular arrhythmias.
    Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B
    N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias.
    Stroobandt R; Andries E; van Mieghem W; Kesteloot H
    Eur Heart J; 1984 Nov; 5(11):876-82. PubMed ID: 6397356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flecainide versus quinidine: results of a multicenter trial.
    Hodges M; Salerno DM; Granrud G
    Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients.
    Salerno DM; Hodges M; Granrud G; Sharkey P
    Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.